262 related articles for article (PubMed ID: 23293885)
1. BIBR 1532 increases arsenic trioxide-mediated apoptosis in acute promyelocytic leukemia cells: therapeutic potential for APL.
Bashash D; Ghaffari SH; Zaker F; Kazerani M; Hezave K; Hassani S; Rostami M; Alimoghaddam K; Ghavamzadeh A
Anticancer Agents Med Chem; 2013 Sep; 13(7):1115-25. PubMed ID: 23293885
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic effect of arsenic trioxide on acute promyelocytic leukemia cells through suppression of NFkβ-dependent induction of hTERT due to down-regulation of Pin1 transcription.
Ghaffari SH; Momeny M; Bashash D; Mirzaei R; Ghavamzadeh A; Alimoghaddam K
Hematology; 2012 Jul; 17(4):198-206. PubMed ID: 22944098
[TBL] [Abstract][Full Text] [Related]
3. Survivin isoform expression in arsenic trioxide-treated acute promyelocytic leukemia cell line and patients: The odd expression pattern of survivin-2α.
Zaki Dizaji M; Ghaffari SH; Hosseini E; Alizadeh N; Rostami S; Momeny M; Alimoghaddam K; Ghavamzadeh A
Asia Pac J Clin Oncol; 2017 Apr; 13(2):e21-e30. PubMed ID: 27770503
[TBL] [Abstract][Full Text] [Related]
4. cAMP protects acute promyelocytic leukemia cells from arsenic trioxide-induced caspase-3 activation and apoptosis.
Safa M; Mousavizadeh K; Noori S; Pourfathollah A; Zand H
Eur J Pharmacol; 2014 Aug; 736():115-23. PubMed ID: 24815320
[TBL] [Abstract][Full Text] [Related]
5. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
[TBL] [Abstract][Full Text] [Related]
6. Direct short-term cytotoxic effects of BIBR 1532 on acute promyelocytic leukemia cells through induction of p21 coupled with downregulation of c-Myc and hTERT transcription.
Bashash D; Ghaffari SH; Zaker F; Hezave K; Kazerani M; Ghavamzadeh A; Alimoghaddam K; Mosavi SA; Gharehbaghian A; Vossough P
Cancer Invest; 2012 Jan; 30(1):57-64. PubMed ID: 22236190
[TBL] [Abstract][Full Text] [Related]
7. Characterization of arsenic-induced cytogenetic alterations in acute promyelocytic leukemia cell line, NB4.
Yaghmaie M; Mozdarani H; Alimoghaddam K; Ghaffari SH; Ghavamzadeh A; Hajhashemi M
Med Oncol; 2012 Jun; 29(2):1209-16. PubMed ID: 21544632
[TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide as first-line treatment for acute promyelocytic leukemia.
Leu L; Mohassel L
Am J Health Syst Pharm; 2009 Nov; 66(21):1913-8. PubMed ID: 19850784
[TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia.
Cai X; Shen YL; Zhu Q; Jia PM; Yu Y; Zhou L; Huang Y; Zhang JW; Xiong SM; Chen SJ; Wang ZY; Chen Z; Chen GQ
Leukemia; 2000 Feb; 14(2):262-70. PubMed ID: 10673743
[TBL] [Abstract][Full Text] [Related]
10. Activation of PPARγ intensified the effects of arsenic trioxide in acute promyelocytic leukemia through the suppression of PI3K/Akt pathway: Proposing a novel anticancer effect for pioglitazone.
Esmaeili S; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Salari S; Gharehbaghian A; Hamidpour M; Bashash D
Int J Biochem Cell Biol; 2020 May; 122():105739. PubMed ID: 32169580
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs contribute to promyelocyte apoptosis in As2O3-treated APL cells.
Liang H; Li X; Wang L; Yu S; Xu Z; Gu Y; Pan Z; Li T; Hu M; Cui H; Liu X; Zhang Y; Xu C; Guo R; Lu Y; Yang B; Shan H
Cell Physiol Biochem; 2013; 32(6):1818-29. PubMed ID: 24356076
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis induction by (+)alpha-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells.
Freitas RA; Silva dos Santos GA; Gimenes Teixeira HL; Scheucher PS; Lucena-Araujo AR; Lima AS; Abreu e Lima RS; Garcia AB; Jordão AA; Falcão RP; Vannucchi H; Rego EM
Leuk Res; 2009 Jul; 33(7):958-63. PubMed ID: 19013639
[TBL] [Abstract][Full Text] [Related]
13. Sodium selenite induces apoptosis in acute promyelocytic leukemia-derived NB4 cells by a caspase-3-dependent mechanism and a redox pathway different from that of arsenic trioxide.
Zuo L; Li J; Yang Y; Wang X; Shen T; Xu CM; Zhang ZN
Ann Hematol; 2004 Dec; 83(12):751-8. PubMed ID: 15480664
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation.
Li Y; Qu X; Qu J; Zhang Y; Liu J; Teng Y; Hu X; Hou K; Liu Y
Cancer Lett; 2009 Nov; 284(2):208-15. PubMed ID: 19457607
[TBL] [Abstract][Full Text] [Related]
15. Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action.
Ghaffari SH; Bashash D; Dizaji MZ; Ghavamzadeh A; Alimoghaddam K
Tumour Biol; 2012 Feb; 33(1):157-72. PubMed ID: 22072212
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells.
Shao W; Fanelli M; Ferrara FF; Riccioni R; Rosenauer A; Davison K; Lamph WW; Waxman S; Pelicci PG; Lo Coco F; Avvisati G; Testa U; Peschle C; Gambacorti-Passerini C; Nervi C; Miller WH
J Natl Cancer Inst; 1998 Jan; 90(2):124-33. PubMed ID: 9450572
[TBL] [Abstract][Full Text] [Related]
17. Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia.
Zheng PZ; Wang KK; Zhang QY; Huang QH; Du YZ; Zhang QH; Xiao DK; Shen SH; Imbeaud S; Eveno E; Zhao CJ; Chen YL; Fan HY; Waxman S; Auffray C; Jin G; Chen SJ; Chen Z; Zhang J
Proc Natl Acad Sci U S A; 2005 May; 102(21):7653-8. PubMed ID: 15894607
[TBL] [Abstract][Full Text] [Related]
18. Salinomycin induces apoptosis and differentiation in human acute promyelocytic leukemia cells.
Zhao Y; Zhong L; Liu L; Yao SF; Chen M; Li LW; Shan ZL; Xiao CL; Gan LG; Xu T; Liu BZ
Oncol Rep; 2018 Aug; 40(2):877-886. PubMed ID: 29989650
[TBL] [Abstract][Full Text] [Related]
19. Fucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivo.
Atashrazm F; Lowenthal RM; Dickinson JL; Holloway AF; Woods GM
Oncotarget; 2016 Jul; 7(29):46028-46041. PubMed ID: 27329592
[TBL] [Abstract][Full Text] [Related]
20. Carnosic Acid-combined Arsenic Trioxide Antileukaemia Cells in the Establishment of NB4/SCID Mouse Model.
Hao L; Ran W; Xiang-Xin L; Lu-Qun W; Xiao-Ning Y
Basic Clin Pharmacol Toxicol; 2016 Sep; 119(3):259-66. PubMed ID: 26998898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
